View in EDS HTML Full Text PDF Full Text

Effectiveness of Switching to Bictegravir/Emtricitabine/Tenofovir Alafenamide from Rilpivirine or Other Non-nucleoside Reverse Transcriptase Inhibitor (NNRTI)-Based Antiretroviral Therapy in Virologically Suppressed People with HIV: A Retrospective Analysis (DRIVE-SWITCH Study)

Saved in:
Bibliographic Details
Title: Effectiveness of Switching to Bictegravir/Emtricitabine/Tenofovir Alafenamide from Rilpivirine or Other Non-nucleoside Reverse Transcriptase Inhibitor (NNRTI)-Based Antiretroviral Therapy in Virologically Suppressed People with HIV: A Retrospective Analysis (DRIVE-SWITCH Study)
Authors: Gagliardini, Roberta1 (AUTHOR), Caioli, Alessandro1 (AUTHOR) alessandro.caioli@gmail.com, Fusto, Marisa1 (AUTHOR), Ottou, Sandrine1 (AUTHOR), Forbici, Federica1 (AUTHOR), Fabeni, Lavinia1 (AUTHOR), Maggi, Fabrizio1 (AUTHOR), Plazzi, Maria Maddalena1 (AUTHOR), De Zottis, Federico1 (AUTHOR), Bellagamba, Rita1 (AUTHOR), Paulicelli, Jessica1 (AUTHOR), Mastrorosa, Ilaria1 (AUTHOR), Grilli, Elisabetta1 (AUTHOR), Pinnetti, Carmela1 (AUTHOR), Mazzotta, Valentina1 (AUTHOR), Caldera, Roberto2 (AUTHOR), Forcina, Gabriele2 (AUTHOR), Antinori, Andrea1 (AUTHOR)
Source: Infectious Diseases & Therapy. May2026, Vol. 15 Issue 5, p1565-1575. 11p.
Database: Academic Search Ultimate
Full text is not displayed to guests.
Description
ISSN:21938229
DOI:10.1007/s40121-026-01330-7